Evidence map›Paper›PMID 40537827›Full record

ArticleBMC chemistry2025

Preparation, characterization and in vitro evaluation of phosphate-doped bioactive glass nanoparticles as promising candidates for therapeutic applications.

Wael M Aboulthana, Sahar M Mousa, Gehan T El-Bassyouni, Esmat M A Hamzawy, Amal G Hussien, M Eltohamy

Abstract read
In one paragraph

Article in BMC chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wael M AboulthanaBiochemistry Department, Biotechnology Research Institute, National Research Centre, 33 El Bohouth St., P.O. 12622, Dokki, Cairo, Egypt. wmkamel83@hotmail.com.
Sahar M MousaInorganic Chemistry Department, Advanced Materials Technology and Mineral Resources Research Institute, National Research Centre, 33 El Bohouth St., P.O. 12622, Dokki, Cairo, Egypt.
Gehan T El-BassyouniRefractories, Ceramics and Building Materials Department, Advanced Materials Technology and Mineral Resources Research Institute, National Research Centre, 33 El Bohouth St., P.O. 12622, Dokki, Cairo, Egypt.
Esmat M A HamzawyGlass Research Department, Advanced Materials Technology and Mineral Resources Research Institute, National Research Centre, 33 El Bohouth St., P.O. 12622, Dokki, Cairo, Egypt.
Amal G HussienBiochemistry Department, Biotechnology Research Institute, National Research Centre, 33 El Bohouth St., P.O. 12622, Dokki, Cairo, Egypt.
M EltohamyGlass Research Department, Advanced Materials Technology and Mineral Resources Research Institute, National Research Centre, 33 El Bohouth St., P.O. 12622, Dokki, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This research focuses on synthesizing bioactive glass nanoparticles with different phosphate concentrations to evaluate their physicochemical characteristics and explore their biomedical potential. The nanoparticles were fabricated by melting a mixture of silica, calcium oxide, sodium oxide, and ammonium dihydrogen phosphate at 1450 °C, followed by ball milling to obtain the optimal particle size distribution. The study systematically investigated the effect of phosphate content on the nanoparticles' structural properties and bioactive performance. Advanced characterization methods; such as XRD, FTIR, DTA, and FE-SEM-EDX were used to examine structural stability and phosphate-induced surface alterations. In vitro assays revealed dose-dependent antioxidant, anti-diabetic, anti-Alzheimer's, anti-arthritic, and anti-inflammatory activities, with higher phosphate content enhancing bioactivity. Results demonstrated enhanced radical scavenging and enzyme inhibition in samples with higher phosphate levels. These findings suggest that phosphate-doped bioactive glass nanoparticles hold significant promise for therapeutic applications. The research advances the understanding of how synthesis parameters influence bioactivity, providing valuable insights for designing next-generation biomedical materials.

Indexed as

Antioxidant and anti-inflammatory effectsBioactive glass nanoparticlesBiomedical applicationsIn vitro bioactivityPhosphate doping

Identifiers

PMID40537827
PMCPMC12180270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.